ESC 365 - PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction .

Back

ESC Professional Premium Access

PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction .

Session: HOT LINE SESSION 5

Topic: Pharmacotherapy

Speaker: Professor J. Alexander (Durham, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor John Alexander

Duke University Medical Center, Durham (United States of America)

3 presentations

0 follower

11 more presentations in this session

INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation.

Speaker: Professor G. Karthikeyan (New Delhi, IN)

Discussant review - INVICTUS.

Speaker: Professor R. Lopes (Durham, US)

Access

Slides

Video

Panel discussion - INVICTUS.

Access

Video

Discussant review - PACIFIC-AMI.

Speaker: Doctor M. O'Donoghue (Boston, US)

Access

Slides

Video

Panel discussion - PACIFIC-AMI.

Access

Video

Access the full session

HOT LINE SESSION 5

Speakers: Professor J. Alexander, Professor G. Karthikeyan, Professor R. Lopes, Doctor M. O'Donoghue

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources